About Translumina Therapeutics Llp
Data last updated: 14 July 2025
Translumina Therapeutics Llp is a limited liability partnership company based in New Delhi, Delhi, India. The LLP has been converted to a Limited Liability Partnership (LLP). For the latest details, refer to the successor LLP entity. It specialises in medical and laboratory equipment, a part of the broader healthcare sector. Incorporated on 01 December 2009, the LLP has been in operation for over 17 years.
Registered with ROC Delhi under LLPIN AAA-0435.
Capital: a total obligation of contribution of ₹1.01 Lakh. It is led by designated partners including Vishal Sharma and Indranil Mukherjee.
Accounts filed on 31 March 2024. Office: Ground Floor Metro Tower Lsc Mor Land New Rajinder Nagar, New Delhi, Delhi, India – 110060.
As per the financials filed for FY 2023, the LLP reported a revenue of ₹375.69 Cr, a growth of 39% compared to the previous year.
The LLP has a workforce of approximately 363 employees as per the latest available data.
The LLP is associated with 1 brand - Translumina. As per MCA filings, the LLP has open charges of ₹60.95 Cr and satisfied charges of ₹9.25 Cr on record.
The LLP has been converted to a Limited Liability Partnership (LLP). For the most current information, refer to the successor LLP entity registered with MCA. The last known website on record is translumina.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Apps
-
Registered AddressGround Floor Metro Tower Lsc Mor Land New Rajinder Nagar, New Delhi, Delhi, India – 110060
-
IndustryHealthcare, Medical & Laboratory Equipment
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Translumina Therapeutics Llp
Translumina Therapeutics Llp operates one associated brand: Translumina. These brands represent Translumina Therapeutics Llp's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Manufacturer of drug-eluting stents and cardiovascular devices. It produces drug-eluting stents, drug-eluting balloons, coronary balloons, and vascular accessories. The company operates advanced manufacturing facilities and is committed to delivering high-quality products. Its focus is on developing and providing innovative cardiovascular intervention technologies. The manufacturing processes adhere to rigorous international standards. | translumina.com |
Competitors & Alternatives of Translumina Therapeutics Llp
Brands and companies operating in the same space as Translumina Therapeutics Llp include SMT, InspireMD, Endospan and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
SMT
|
SMT is recognized as a developer of cardiovascular medical devices. | Surat, India, India | 1998 |
InspireMD
|
Proprietary stent systems with bio-stable mesh are developed and commercialized. | Boston, United States, United States | 2005 |
Endospan
|
Endovascular stent graft systems for aortic aneurysm repair are developed. | Herzliya, Israel, Israel | 2009 |
Vesper Medical
|
Venous stent system is developed for deep vein disease treatment. | Wayne, United States, United States | 2016 |
STENTiT
|
Developer of regenerative stent for vascular disorders | Eindhoven, Netherlands, Netherlands | 2007 |
Veryan Medical
|
Three-dimensional vascular stents for peripheral vascular disease are developed. | Horsham, United Kingdom, United Kingdom | 2003 |
Biosensors International
|
Products for interventional cardiology and critical care procedures | Singapore, Singapore, Singapore | 1990 |
Huamai Tyco
|
Abdominal aortic stent systems are developed for disease treatment. | Beijing, China, China | 2011 |
Lombard Medical
|
Endovascular stent grafts are developed, manufactured, and marketed. | Irvine, United States, United States | 2000 |
Designated Partners of Translumina Therapeutics Llp
Translumina Therapeutics Llp is currently managed by 6 designated partners, with 2 former designated partners having served the organization. The current Designated Partners play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vishal Sharma | Designated Partner | 11 Mar 2020 | 6 Years 5 Months | As last reported |
|
Indranil Mukherjee
Also directs:
Translumina Therapeutics Private Limited, Halemed Medical Private Limited, Transvalve Health Private Limited and 1 more
|
Designated Partner | 15 Mar 2024 | 2 Years 5 Months | As last reported |
|
Gurmit Singh Chugh
Also directs:
Pathway Medical Llp, Advance Therapeutics Llp, Translumina Therapeutics Private Limited and 5 more
|
Partner | 17 May 2019 | 7 Years 3 Months | As last reported |
|
Avnish Mehra
Also directs:
Translumina Therapeutics Private Limited, Integris Medtech Limited, Halemed Medical Private Limited and 4 more
|
Partner | 11 Mar 2020 | 6 Years 5 Months | As last reported |
| Punita Sharma | Designated Partner | 01 Dec 2009 | 16 Years 8 Months | As last reported |
|
Vishal Omprakash Goenka
Also directs:
Translumina Therapeutics Private Limited, Integris Medtech Limited, Halemed Medical Private Limited and 3 more
|
Designated Partner | 15 Mar 2024 | 2 Years 5 Months | As last reported |
Financials of Translumina Therapeutics Llp FY 2024 filings available
Translumina Therapeutics Llp reported revenue of ₹375.69 Cr (up 39.00% YoY) for FY 2023.
Ten-year financial statements for Translumina Therapeutics Llp
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Translumina Therapeutics Llp
Shareholding and ownership data for Translumina Therapeutics Llp
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Translumina Therapeutics Llp
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Nov 2022 | Hdfc Bank Limited | ₹23 Lakh | Open |
| 30 Aug 2022 | Icici Bank Limited | ₹10 Cr | Open |
| 20 Apr 2022 | Hdfc Bank Limited | ₹16.06 Lakh | Open |
| 28 Jan 2022 | Hdfc Bank Limited | ₹50 Cr | Open |
| 27 Nov 2021 | Hdfc Bank Limited | ₹7.97 Lakh | Open |
Total charge records: 8 View all charges
Employees and EPFO Compliance at Translumina Therapeutics Llp
Translumina Therapeutics Llp has a workforce of 363 employees as of Feb 08, 2025.
Employee and EPFO history for Translumina Therapeutics Llp
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Translumina Therapeutics Llp
GST registrations and filing compliance for Translumina Therapeutics Llp
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Translumina Therapeutics Llp
Credit ratings, litigation, and regulatory alerts for Translumina Therapeutics Llp
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Translumina Therapeutics Llp
MSME payment history for Translumina Therapeutics Llp
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Translumina Therapeutics Llp
Corporate group structure for Translumina Therapeutics Llp
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Translumina Therapeutics Llp
MCA filings and documents for Translumina Therapeutics Llp
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Translumina Therapeutics Llp
Frequently Asked Questions about Translumina Therapeutics Llp
Translumina Therapeutics Llp has been "Converted to LLP" - the business changed its legal structure from a company to a Limited Liability Partnership. The original company no longer exists in its previous form. For the latest information, refer to the successor LLP entity registered with MCA.
Translumina Therapeutics Llp is a former company now converted to LLP, previously operating as a limited liability partnership in the healthcare sector based in New Delhi, Delhi, India. It was incorporated on 01 December 2009 and is registered under LLPIN AAA-0435. For the latest details, refer to the successor LLP entity.
The LLPIN (Limited Liability Partnership Identification Number) of Translumina Therapeutics Llp is AAA-0435. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
The current designated partners of Translumina Therapeutics Llp are:
- Vishal Sharma - Designated Partner
- Indranil Mukherjee - Designated Partner
- Gurmit Singh Chugh - Partner
- Avnish Mehra - Partner
- Punita Sharma - Designated Partner
- Vishal Omprakash Goenka - Designated Partner
The primary industry of Translumina Therapeutics Llp is healthcare. The LLP specifically operates in medical and laboratory equipment.
Translumina Therapeutics Llp was incorporated on 01 December 2009. Registered with ROC Delhi.